20
Centaur Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MILNACIPRAN HYDROCHLORIDE, with a corresponding US DMF Number 26577.
Remarkably, this DMF maintains an Active status since its submission on December 03, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 09, 2013, and payment made on December 08, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II